Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2.

Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2. J Immunol. 2009 May 01; 182(9):5633-40.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.